About
Alpha-9 Oncology is a clinical-stage company developing targeted radiopharmaceuticals that use bespoke molecules to deliver precise cancer treatment, including alpha-emitting therapeutics and imaging agents.
Explore Alpha-9 Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.